Use of Transcarotid Artery Revascularization, Transfemoral Carotid Artery Stenting, and Carotid Endarterectomy in the US From 2015 to 2019

IMPORTANCE: A transcarotid artery revascularization (TCAR) device was approved by the US Food and Drug Administration in 2015 for carotid revascularization in patients at high risk for stroke, cranial nerve injury, or major cardiac event. It is unclear how the introduction of TCAR has changed the us...

Descripción completa

Detalles Bibliográficos
Autores principales: Stonko, David P., Goldsborough, Earl, Kibrik, Pavel, Zhang, George, Holscher, Courtenay M., Hicks, Caitlin W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482062/
https://www.ncbi.nlm.nih.gov/pubmed/36112371
http://dx.doi.org/10.1001/jamanetworkopen.2022.31944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482062/
https://www.ncbi.nlm.nih.gov/pubmed/36112371
http://dx.doi.org/10.1001/jamanetworkopen.2022.31944

Ejemplares similares